The Valley Desk

NCT00625456 · Interventional trial

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

Overall registry status Completed

Phase 1

Conditions Lung Cancer, Melanoma, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov